Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...

Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...

Eli Lilly is deepening its presence in the non-opioid pain field by buying California biotech SiteOne Therapeutics, which is ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today announced the launch of its innovative Cloud Lab platform ...

Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA for the sleep ...

Of Florida’s 30-member delegation, at least seven don’t own, buy or sell stocks, nor do their spouses or dependent children, ...

The order aims to slash drug prices by up to 80%. Indian industry had been on edge since March amid threats of reciprocal ...

Eli Lilly has unveiled plans to expand its long-standing partnership with Purdue University, with the drugmaker investing up ...

Eli Lilly and Company and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Eli Lilly and Company and Purdue University are keeping their partnership alive beyond it’s previously expected years. In an announcement made Friday, Lilly said they will invest up to $250 million ...